BSTN news

Latest 1 stories · newest Nov 20, 2026

BSTN
Brainstorm settles specific derivative litigation

Brainstorm Cell Therapeutics Inc. filed notice regarding a proposed settlement of a stockholder derivative action and the dismissal of a separate Section 220 inspection demand in New York federal court.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same BSTN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/BSTN/newsSTART FREE